- ￥1668
- abinScience
- China
- HA577013
- 2025年07月25日
- ELISA, WB, IP, FCM
- Alpaca
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Alpaca
- 亚型：
VHH-His
- 形态：
Liquid
- 保存条件：
0.01M PBS pH 7.4
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1 year
- 抗原来源：
Alpaca
- 目录编号：
HA577013
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Alpaca
- 应用范围：
ELISA, WB, IP, FCM
- 浓度：
1mg/mL
- 靶点：
Atypical chemokine receptor 1, Duffy antigen receptor for chemokines, Duffy antigen/chemokine receptor, Duffy blood group antigen, Fy glycoprotein, GpFy, Glycoprotein D, Plasmodium vivax receptor, CD234, ACKR1, FY, GPD
- 抗体英文名：
Anti-Human ACKR1/CD234 Nanobody (SAA2301)
- 抗体名：
Anti-Human ACKR1/CD234 Nanobody (SAA2301)
- 规格：
100ul
| Product name | Anti-Human ACKR1/CD234 Nanobody (SAA2301) |
|---|---|
| Catalog No. | HA577013 |
| Host species | Alpaca |
| Species reactivity | Human |
| Immunogen | / |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | VHH-His |
| Applications | ELISA, WB, IP, FCM |
| Target | Atypical chemokine receptor 1, Duffy antigen receptor for chemokines, Duffy antigen/chemokine receptor, Duffy blood group antigen, Fy glycoprotein, GpFy, Glycoprotein D, Plasmodium vivax receptor, CD234, ACKR1, FY, GPD |
| Purification | Purified by Nickel column. |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | / |
| Accession | Q16570 |
| Alternative Names | / |
| Clone ID | SAA2301 |
| Species | / |
| Product Usage Information | / |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验). They were isolated by gradient density centrifugation using Lymphoprep (Nycomed, Oslo, Norway). CD19+ B lymphocytes were purified by positive selection using anti-CD19-conjugated magnetic beads and a VarioMacs magnetic cell sorter (Miltenyi Biotec, Bergisch Gladbach
) A431 cells. At 48 h after infection, these cells were stained with ten different primary antibodies (5 g/ml) specific for different cell surface markers: anti-CD15 (clone 2F3; BD, PharMingen, San Diego, CA), anti-ERBB-2 (clone SP77; ref. 5), anti-ERBB
凋亡”途径，使得从小鼠中获取较多数量的活性细胞比较困难，也成为这类研究的桎梏。 为此，研发人员推出了Treg-ProtectorTM（anti-ARTC Nanobody）产品，该纳米抗体能够有效抑制NAD+与 ARTC2的结合，从而抑制因损伤等刺激性条件引起NAD+诱导的细胞凋亡途径，从而提高活性细胞的数量。研究结果表明，将这种纳米抗体注射到小鼠体内能有助于收集活性Treg细胞的数量，就像获取NK细胞的方法一样, 实验结果可以观察到注射了Treg-ProtectorTM小鼠的脾脏细胞中Treg的细胞
技术资料暂无技术资料 索取技术资料
